Author:
Pacilio C, ,Morabito A,Nuzzo F,Gravina A,Labonia V,Landi G,Rossi E,De Maio E,Di Maio M,D'aiuto G,Botti G,Normanno N,Chiodini P,Gallo C,Perrone F,de Matteis A
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Buzdar AU, Legha SS, Hortobagyi GN, Yap HY, Wiseman CL, Distefano A, Schell FC, Barnes BC, Campos LT, Blumenschein GR (1981) Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens. Cancer 47: 2798–2802
2. Chan S, Friedrichs K, Noel D, Pinter T, Van Belle S, Vorobiof D, Duarte R, Gil Gil M, Bodrogi I, Murray E, Yelle L, von Minckwitz G, Korec S, Simmonds P, Buzzi F, Gonzalez Mancha R, Richardson G, Walpole E, Ronzoni M, Murawsky M, Alakl M, Riva A, Crown J, 303 Study Group (1999) Prospective randomized trial of docetaxel vs doxorubicin in patients with metastatic breast cancer. J Clin Oncol 17: 2341–2354
3. Chauvin F, Magnet M, Lasset C, Catimel G, Mayer M, Chevarier P, Jacquin JP, Peaud P, Clavel M (1990) Prognostic factors in the response of a first line chemotherapy in advanced breast cancer. Bull Cancer 77: 941–947
4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687–1717
5. Fossati R, Confalonieri C, Torri V, Ghislandi E, Penna A, Pistotti V, Tinazzi A, Liberati A (1998) Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomised trials involving 31 150 women. J Clin Oncol 16: 3439–3460
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献